InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.72
(
-0.07%
)
US TECH 100
19,042.80
(
-0.86%
)
Dow Jones
39,400.99
(
0.64%
)
Brent Oil
85.25
(
1.46%
)
Bitcoin
59,962.66
(
-5.05%
)
Post# of 252321
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

hugbu

Send PM Follow Ignore
Followers 1
Posts 5
Boards Moderated 0
Alias Born 02/07/2010

hugbu

Re: None

Friday, 03/05/2010 3:41:31 AM

Friday, March 05, 2010 3:41:31 AM

Post# of 252321
A biotech with some value :

Galapagos reports record revenues and net profit for 2009, foresees sustained profitability
• Total revenues of €106 M (+34%)
• Group net profit of €3 M
• R&D revenues of €63.8 M (+76%), driven by alliances
• BioFocus recurrent segment profit of €7.9 M (+174%)
• Cash position of €47.4 M at year-end
• Four programs moved into clinical development
• 2010 guidance: profitability and positive cash-flow, revenues more than €135 million

www.glpg.com

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up